Latest revenue
$3.98B
as of 2026-03-31
Latest net income
$369.0M
as of 2026-03-31
Net margin
9.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $39.67B
- Enterprise value
- $39.67B
- P/E (trailing)
- 28.1×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $37.34
- 52-wk low
- $14.99
- Beta
- —
- Shares out
- 1.16B
5-year trend
About TEVA
Business description and risk factors will appear here once TEVA's latest filing is fully ingested.
Profitability
Gross margin
51.8%
6.3%Operating margin
12.5%
782.4%Net margin
8.2%
182.5%Return on equity
17.8%
158.4%Return on assets
3.5%
183.0%Leverage
Debt / equity
4.15×
34.3%Long-term debt / equity
1.89×
36.4%Debt / assets
80.6%
6.7%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $3.98B | +2.3% | $369.0M | +72.4% | 9.3% |
Q4 2025 2025-12-31 | $4.71B | +11.4% | $481.0M | +321.7% | 10.2% |
Q3 2025 2025-09-30 | $4.48B | +3.4% | $433.0M | +199.1% | 9.7% |
Q2 2025 2025-06-30 | $4.18B | +0.3% | $282.0M | +133.3% | 6.8% |
Q1 2025 2025-03-31 | $3.89B | +1.9% | $214.0M | +254.0% | 5.5% |
Q4 2024 2024-12-31 | $4.23B | — | $-217.0M | — | -5.1% |
Q3 2024 2024-09-30 | $4.33B | +12.5% | $-437.0M | -733.3% | -10.1% |
Q2 2024 2024-06-30 | $4.16B | +7.4% | $-846.0M | +2.0% | -20.3% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Pharmaceutical Preparations · SIC 2834
Your notes
Keep private notes on TEVA — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$21.0K
Insider selling
$93.5M
Net activity
−$93.5M
Distinct insiders
13
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns TEVA
Institutional value
$7.67B
Total shares held
355.2M
Distinct holders
432
As of
2026-03-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 65.1M | $1.96B | — | New |
| 2 | Phoenix Financial Ltd. | 42.8M | $1.29B | — | New |
| 3 | WCM INVESTMENT MANAGEMENT, LLC | 40.8M | $1.16B | — | New |
| 4 | Capital World Investors | 8.8M | $266.1M | — | New |
| 5 | JPMORGAN CHASE & CO | 6.8M | $191.7M | — | New |
| 6 | Swiss National Bank | 4.2M | $127.3M | — | New |
| 7 | SOUND SHORE MANAGEMENT INC /CT/ | 3.9M | $117.0M | — | New |
| 8 | Legal & General Group Plc | 3.9M | $116.6M | — | New |
| 9 | TODD ASSET MANAGEMENT LLC | 3.8M | $113.6M | — | New |
| 10 | AustralianSuper Pty Ltd | 3.6M | $107.1M | — | New |
| 11 | Invesco Ltd. | 3.3M | $98.0M | — | New |
| 12 | DIMENSIONAL FUND ADVISORS LP | 2.9M | $86.2M | — | New |
| 13 | DEUTSCHE BANK AG\ | 2.8M | $85.2M | — | New |
| 14 | Capital International Investors | 2.8M | $85.0M | — | New |
| 15 | Nuveen, LLC | 2.7M | $82.6M | — | New |
| 16 | National Pension Service | 2.3M | $69.1M | — | New |
| 17 | Sumitomo Mitsui Trust Group, Inc. | 2.2M | $65.5M | — | New |
| 18 | SEB Asset Management AB | 2.0M | $59.6M | — | New |
| 19 | UBS Group AG | 1.9M | $56.5M | — | New |
| 20 | Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) | 1.9M | $56.5M | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once TEVA's latest filing finishes processing.